PlainRecalls
FDA Devices Moderate Class II Terminated

Elecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma Catalog number: 07026773190

Reported: December 18, 2019 Initiated: October 28, 2019 #Z-0669-2020

Product Description

Elecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma Catalog number: 07026773190

Reason for Recall

Current software version of the Anti-HAV IgM APP-file (version 06.05-101) downloaded an erroneous Border Area setting, (1.0 1.00) instead of (0.90 1.10).

Details

Units Affected
712 units
Distribution
US Nationwide distribution.
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Elecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma Catalog number: 07026773190. Recalled by Roche Diagnostics Operations, Inc.. Units affected: 712 units.
Why was this product recalled?
Current software version of the Anti-HAV IgM APP-file (version 06.05-101) downloaded an erroneous Border Area setting, (1.0 1.00) instead of (0.90 1.10).
Which agency issued this recall?
This recall was issued by the FDA Devices on December 18, 2019. Severity: Moderate. Recall number: Z-0669-2020.